State launches all‑payer claims database with public cost and condition dashboards, officials say
Loading...
Summary
Office of Healthcare Strategy and the Georgia Tech Research Institute presented the state’s all‑payer claims database (APCD) as operational, reporting data from more than 39 submitters covering roughly 7–8 million Georgians and public dashboards that compare costs and conditions by ZIP code and payer type.
Officials from the Office of Healthcare Strategy (OPB/OHSC) and the Georgia Tech Research Institute briefed the committee on the newly operational all‑payer claims database (APCD) and demonstrated public dashboards for cost and condition analysis.
Stephanie Beck (appearing for OHSC) said the state invested approximately $8.8 million to implement APCD over three years and leveraged federal Medicaid dollars to cover roughly 90% of that cost; the state has requested and received CMS operational funding through federal fiscal year 2027 to support ongoing work.
Dr. John Duke of the GTRI Center for Health Analytics described the data coverage and use cases: more than 39 separate medical and dental submitters provide quarterly uploads covering an estimated 7–9 million Georgians and the system stores hundreds of millions to over a billion claim records. He demonstrated a consumer‑facing cost comparison tool that allows users to select procedures, compare median costs by provider and filter by ZIP‑code distance and payer type, and a condition explorer that maps chronic‑disease prevalence and related costs.
Duke and Beck told the committee that required submitters (payers with thresholds set by rule) are largely in place, that ERISA self‑insured employers are not mandated to submit under federal guidance, and that the APCD has already approved ten external research projects. The presenters said the APCD is used by state agencies for maternal health, epidemiology and Medicaid/Medicare market analysis and that universities, nonprofits and local governments have requested access for research and policy work.
Members asked about submitter lists, mobile accessibility and whether the claims data can be used to infer outcomes or be linked to registries. Duke said the APCD is longitudinal, can follow patients across payers and geographies and can support certain outcome‑focused analyses from claims; he also said the team is exploring registry linkages, beginning with oncology, and noted further connections to clinical data would expand outcome measurement.
Committee feedback was largely positive; the panel offered to provide a submitter list and follow up on GLP‑1 utilization breakdowns and other data requests. The Chair recessed the committee for lunch.
